GGrantIndex
← Search

CURCUMIN-QINGDAI (CURQD) IN COMBINATION WITH VEDOLIZUMAB VERSUS VEDOLIZUMAB ALONE AS INDUCTION AND MAINTENANCE THERAPY IN ULCERATIVE COLITIS

$811,213FY2025Defense Health AgencyDOD

Icahn School Of Medicine At Mount Sinai, New York NY

Investigators

View source on USAspending →